Abstract
Compound LY354740 [(+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid], an analog of glutamic acid, is a selective group 2 metabotropic glutamate receptor agonist in clinical development for the treatment of anxiety. Studies have been conducted to characterize the absorption, disposition, metabolism, and excretion of LY354740 in rats and dogs after intravenous bolus or oral administration. Plasma concentrations of LY354740 were measured using a validated gas chromatography/mass spectrometry assay. In rats, LY354740 demonstrated linear pharmacokinetics after oral administration from 30 to 1000 mg/kg. The oral bioavailability of LY354740 was approximately 10% in rats and 45% in dogs. In the dog, food decreased the mean area under the plasma concentration-time curve value by approximately 34%, hence, decreasing the oral bioavailability of the compound. Excretion studies in both rats and dogs indicate that the absorbed drug is primarily eliminated via renal excretion. In addition, tissue distribution in rats showed that the highest levels of radioactivity were in the kidney and gastrointestinal tract, which is consistent with the excretion studies. Metabolism of LY354740 was evaluated in vitro using rat and dog liver microsomes and rat liver slices. In addition, urine and fecal samples from rat and dog excretion studies were profiled using HPLC with radio-detection. These evaluations indicated that neither rats nor dogs metabolized LY354740. In summary, LY354740 is poorly absorbed in rats, moderately absorbed in dogs, and rapidly excreted as unchanged drug in the urine.
Footnotes
- Abbreviations used are::
- LY354740
- (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid
- LSN338771
- 2-amino-6-(2-caboxyethyl)-bicyclo[3.1.0]hexane-2-carboxylic acid
- mGlu
- metabotropic glutamate
- GC/MS
- gas chromatography/mass spectrometry
- HPLC
- high-performance liquid chromatography
- QWBA
- quantitative whole-body autoradiography
- BQL
- below quantitation limit
- AUC
- area under the plasma concentration versus time curve
- Cmax
- maximum plasma concentration
- Tmax
- time to reach maximum plasma concentration
- ke
- elimination rate constant
- MRT
- mean residence time
- Vdss
- volume of distribution at steady state
- VdB
- apparent volume of distribution
- Received April 10, 2001.
- Accepted July 18, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|